isoproterenol has been researched along with cardiovascular agents in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (25.61) | 18.7374 |
1990's | 16 (19.51) | 18.2507 |
2000's | 16 (19.51) | 29.6817 |
2010's | 24 (29.27) | 24.3611 |
2020's | 5 (6.10) | 2.80 |
Authors | Studies |
---|---|
Adams, HR; Parker, JL | 1 |
Astrup, T; Brakman, P; Epstein, SE; Redwood, DR; Rosing, DR | 1 |
Boudoulas, H; Leier, CV; Lewis, RP; Rittgers, SE; Weissler, AM | 1 |
Miyazaki, H | 1 |
Crowley, MR; Fineman, JR; Soifer, SJ | 1 |
Anger, H; Mentz, P; Mest, HJ | 1 |
Rodger, IW; Shahid, M | 1 |
Evdokimov, EI; Stets, VR; Tishkin, VS | 1 |
Kapoor, NK; Kaul, S | 1 |
Morgan, G; Siegl, PK | 1 |
Higgins, CB; Mancini, GB; Mattrey, RF; Peck, WW; Slutsky, RA | 1 |
Millar, JS; Williams, EM | 1 |
Hageman, WE; Jacoby, HI; Pruss, TP | 1 |
Mentzer, RM; Moss, RL; Strang, KT | 1 |
Abou-Mohamed, G; Caldwell, RW; Ibrahim, TM; Tuttle, RR | 1 |
Abou-Mohamed, G; Caldwell, RW; Carrier, GO; Elmazar, MM; Tuttle, RR | 1 |
De Mey, C | 1 |
Kajio, F; Morishima, M; Nakazawa, M; Tomita, H; Tomita, SM | 1 |
Haslam, RJ; Lee, RM; Maurice, DH | 1 |
Breall, JA; Grossman, W; Watanabe, J | 1 |
Iimura, O; Miura, T; Ogawa, T; Shimamoto, K | 1 |
Eichler, HG; Kastner, J; Krejcy, K; Schmetterer, L; Unfried, C; Wolzt, M; Zanaschka, G | 1 |
Fercher, AF; Rheinberger, A; Salomon, A; Schmetterer, L; Unfried, C; Wolzt, M; Zanaschka, G | 1 |
Maccaferri, G; McBain, CJ | 1 |
Friedman, E; Gao, E; Horwitz, J; Johnson, MD; Roberts, J; Snyder, DL | 1 |
Sakamoto, T; Suzuki, A | 1 |
Chiba, S; Furukawa, Y; Hoyano, Y; Kasama, M; Oguchi, T | 1 |
Bun, H; Furuya, K; Kiyohara, T; Miyata, S; Nakai, S | 1 |
Malati, T; Naidu, MU; Naik, P; Rajasekhar, A; Ratnakar, KS | 1 |
Bodor, N; Juhász, A | 1 |
Chen, J; Christopher, TA; Gao, F; Gu, J; Lopez, BL; Lysko, P; Ma, XL; Ohlstein, EH; Ruffolo, RR; Yue, TL | 1 |
Chen, IJ; Chiang, LC; Chiu, CC; Liang, JC; Lin, YT; Tsai, CH; Wu, JR; Yeh, JL | 1 |
Leffler, CW; Willis, AP | 1 |
Akdeniz, B; Aslan, O; Badak, O; Goldeli, O; Guneri, S; Keskin, V; Kirimli, O; Tekin, U | 1 |
Gainullin, AA; Zefirov, AL; Zefirov, TL; Ziyatdinova, NI | 1 |
Belluti, F; Bisi, A; Budriesi, R; Chiarini, A; Gobbi, S; Ioan, P; Rampa, A; Valenti, P; Valoti, E | 1 |
BEAUVALLET, M; GIUDICELLI, R; HAZARD, R | 2 |
TAKEO, Y; YUI, T | 1 |
KONZETT, H | 1 |
CHASSON, J; GRIMAUD, C; NICOLI, M | 1 |
BOUCKAERT, J; DESCHAEPDRYVER, AF; HEYMANS, C; NAGASAKA, M | 1 |
ALDINGER, EE | 1 |
SIMONSSON, BG | 1 |
Devaki, T; Ebenezar, KK; Sathish, V | 1 |
Adcock, IM; Anker, SD; Bolger, AP; Dietz, R; Genth-Zotz, S; Kalra, PR; Kemp, M; Poole-Wilson, PA; von Haehling, S | 1 |
Angelone, T; Cerra, MC; Corti, A; De Iuri, L; Tota, B | 1 |
Ferrick, KJ; Fisher, JD; Goldie, SJ; Gross, JN; Kim, SG; O'Mara, JE; Palma, EC | 1 |
Antonios, S; Azar, R; Jazra, C; Kassab, R; Neemtallah, R; Salamé, E | 1 |
Evlakhov, VI; Poyasov, IZ; Tkachenko, BI | 1 |
Devika, PT; Prince, PS | 1 |
Mehta, JL; Srivastava, G | 1 |
Gong, S; Guan, T; Li, Y; Sun, H; Wu, X; Yao, Z | 1 |
Armstead, WM; Cines, DB; Higazi, AA; Kiessling, JW; Riley, J | 1 |
Chen, CX; Gao, JP; Gu, WL; Lü, J; Wang, Y; Wu, Q | 1 |
Akinmoladun, AC; Barthwal, MK; Dikshit, M; Farombi, EO; Obuotor, EM | 1 |
Guerron, AD; Hoffman, EP; Nagaraju, K; Sali, A; Spurney, CF; van der Meulen, JH; Yu, Q | 1 |
Baker, JG; Fretwell, L; Gardiner, SM; Hill, SJ; Kemp, P; March, J | 1 |
Chen, J; Li, L; Wan, LH; Xiong, WB; Zhou, LM | 1 |
Abdul Kareem, M; Lakshmi Devi, K; Rasool, SN; Saayi Krushna, G; Shaik, AH; Vikram Kumar Reddy, A | 1 |
Pangayarselvi, B; Prathapan, A; Raghu, KG; Sankar, V | 1 |
Evangelou, AM; Karkabounas, SCh; Kolentinis, MK; Kolettis, TM; Simos, YV; Tsitou, NCh; Verginadis, II | 1 |
Liu, CH; Wang, YQ; Yu, BY; Zhang, JQ; Zhu, DN | 1 |
Kim, K; Kim, SB; Koo, KI; Oh, J | 1 |
Bett, GC; Kaplan, AD; Kim, JJ; Lin, B; London, B; Rasmusson, RL; Salama, G; Sun, B; Yang, L; Zhu, X | 1 |
Agnati, LF; Carone, C; Cortelli, P; Filaferro, M; Fuxe, K; Genedani, S; Guescini, M; Guidolin, D; Leo, G; Marcoli, M; Maura, G; Sisti, D; Stocchi, V | 1 |
Hileman, S; Huang, J; Hull, R; Lin, YC; Martin, KH; Yu, HG | 1 |
Dai, DZ; Dai, Y; Du, RH; Hussein, HK; Li, M; Shi, FH; Tang, YQ | 1 |
Aonuma, K; Hasebe, H; Hatano, N; Iida, M; Muramatsu, T; Yoshida, K | 1 |
Ahmed, LA; Attia, WA; Khattab, MM; Mohamed, SS | 1 |
Al-Assad, W; Ansari, S; Bogun, F; Chugh, A; Crawford, T; Ghanbari, H; Huether, E; Hussain-Amin, A; Jani, R; Jongnarangsin, K; Latchamsetty, R; Morady, F; Oral, H | 1 |
Antzelevitch, C; Barajas-Martinez, H; Gurabi, Z; Hu, D; Koncz, I; Patocskai, B | 1 |
Chang, CJ; Chen, SA; Chen, YC; Chen, YJ; Cheng, CC; Kao, YH | 1 |
Mohammed Sadullah, SS; Niranjali Devaraj, S; Rathinavel, A; Sankar, J | 1 |
Khwaja, S; Mahmood, T; Siddiqui, HH | 1 |
Ali, SS; Boon, YW; Mohamed, SFA; Rozalei, NH; Zainalabidin, S | 1 |
Carrillo, ED; García, MC; Hernández, A; Narasimhan, G; Sánchez, JA | 1 |
Cheng, M; Fang, Y; Feng, J; Jin, Y; Liu, J; Liu, W; Sun, Y; Tu, L | 1 |
Jeong, YJ; Kim, ES; Lee, BK; Lee, DW; Oyunbaatar, NE; Shanmugasundaram, A | 1 |
Huang, J; Huang, L; Jiang, M; Shen, H; Wang, Q; Yuan, Y | 1 |
Liu, A; Shang, Z; Zhang, Y | 1 |
Li, AY; Li, Y; Liu, WZ; Liu, XC; Song, QH; Sun, JH; Xu, GR; Yang, HX; Zhang, C; Zhang, Y; Zhou, WW | 1 |
3 review(s) available for isoproterenol and cardiovascular agents
Article | Year |
---|---|
Pharmacologic management of circulatory shock: cardiovascular drugs and corticosteroids.
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Animals; Cardiovascular Agents; Dopamine; Epinephrine; Isoproterenol; Norepinephrine; Receptors, Adrenergic, alpha; Shock | 1979 |
[Postoperative cardiac care: theoretical use of various cardiovascular agents].
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Dopamine; Epinephrine; Humans; Isoproterenol; Postoperative Care; Vasoconstrictor Agents; Vasodilator Agents | 1985 |
Currying the heart: curcumin and cardioprotection.
Topics: Adrenergic beta-Agonists; Animals; Antibiotics, Antineoplastic; Cardiovascular Agents; Curcumin; Doxorubicin; Endothelium, Vascular; Heart Diseases; Humans; Isoproterenol; Muscle, Smooth, Vascular; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Signal Transduction | 2009 |
7 trial(s) available for isoproterenol and cardiovascular agents
Article | Year |
---|---|
Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.
Topics: Administration, Oral; Adolescent; Adult; Cardiovascular Agents; Clinical Trials as Topic; Coronary Circulation; Deslanoside; Diastole; Dobutamine; Heart Rate; Humans; Infusions, Parenteral; Injections, Intravenous; Isoproterenol; Lidocaine; Male; Myocardial Contraction; Propranolol; Time Factors | 1979 |
Method specificity of the auscultatory estimates of the inodilatory reduction of diastolic blood pressure based on Korotkoff IV and V criteria.
Topics: Administration, Oral; Adult; Blood Pressure; Blood Pressure Determination; Cardiotonic Agents; Cardiovascular Agents; Celiprolol; Cross-Over Studies; Eating; Epinephrine; Heart Rate; Humans; Imidazoles; Infusions, Intravenous; Isoproterenol; Male; Phosphodiesterase Inhibitors; Pyridazines; Reproducibility of Results; Vasodilator Agents | 1995 |
Short-term drug effects on the signal-averaged electrocardiogram in healthy men: assessment of intra- and interindividual variability of spectral temporal mapping and time-domain analysis.
Topics: Adenosine; Adult; Atropine; Cardiovascular Agents; Cross-Over Studies; Electrocardiography; Heart; Hemodynamics; Humans; Isoproterenol; Lidocaine; Male; Norepinephrine; Placebos; Propranolol; Reference Values; Reproducibility of Results; Time Factors; Verapamil | 1995 |
Effect of isoproterenol, phenylephrine, and sodium nitroprusside on fundus pulsations in healthy volunteers.
Topics: Adrenergic beta-Agonists; Adult; Cardiovascular Agents; Choroid; Cross-Over Studies; Double-Blind Method; Female; Fundus Oculi; Humans; Interferometry; Isoproterenol; Male; Nitroprusside; Phenylephrine | 1996 |
Head-up tilt table testing with low dose sublingual isosorbide dinitrate in the evaluation of unexplained syncope: a comparison with isoproterenol infusion.
Topics: Administration, Sublingual; Adult; Cardiovascular Agents; Female; Humans; Infusions, Intravenous; Isoproterenol; Isosorbide Dinitrate; Male; Middle Aged; Sensitivity and Specificity; Syncope; Syncope, Vasovagal; Tilt-Table Test | 2002 |
[Sensitization of tilt-table testing for syncope of unknown etiology: which drug to use?].
Topics: Administration, Sublingual; Adolescent; Adult; Aged; Blood Pressure; Cardiotonic Agents; Cardiovascular Agents; Electrocardiography; Female; Heart Rate; Humans; Infusions, Intravenous; Isoproterenol; Male; Middle Aged; Nitroglycerin; Predictive Value of Tests; Sensitivity and Specificity; Syncope, Vasovagal; Tilt-Table Test; Vasodilator Agents | 2006 |
Role of adenosine after antral pulmonary vein isolation of paroxysmal atrial fibrillation: A randomized controlled trial.
Topics: Adenosine; Aged; Atrial Fibrillation; Cardiovascular Agents; Catheter Ablation; Female; Humans; Intraoperative Care; Isoproterenol; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Recurrence; Treatment Outcome | 2016 |
72 other study(ies) available for isoproterenol and cardiovascular agents
Article | Year |
---|---|
The fibrinolytic response of man to vasoactive drugs measured in arterial blood.
Topics: Adolescent; Adult; Arteries; Blood; Cardiovascular Agents; Epinephrine; Female; Fibrinolysis; Humans; Isoproterenol; Male; Nicotinic Acids; Nitroglycerin; Phentolamine; Phenylephrine; Physical Exertion | 1978 |
[Effects of cardiotonic and vasoactive drugs on the central nervous system during resuscitation (author's transl)].
Topics: Animals; Blood Circulation; Brain; Cardiovascular Agents; Dogs; Dopamine; Epinephrine; Isoproterenol; Lidocaine; Norepinephrine; Resuscitation | 1979 |
Effects of vasoactive drugs on thromboxane A2 mimetic-induced pulmonary hypertension in newborn lambs.
Topics: Animals; Animals, Newborn; Cardiovascular Agents; Dobutamine; Dopamine; Hemodynamics; Hypertension, Pulmonary; Isoproterenol; Nitroprusside; Prostaglandin Endoperoxides, Synthetic; Sheep; Thromboxane A2 | 1991 |
Interaction of iloprost and indomethacin with the cardiac effects of isoprenaline, ouabain and trapidil.
Topics: Animals; Atrial Function; Cardiovascular Agents; Drug Interactions; Epoprostenol; Guinea Pigs; Heart; Heart Rate; Iloprost; In Vitro Techniques; Indomethacin; Isoproterenol; Myocardial Contraction; Ouabain; Pyrimidines; Trapidil | 1988 |
Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition.
Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Carbamates; Cardiovascular Agents; Cyclic AMP; Cyclic GMP; Electric Stimulation; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Rabbits; Theophylline | 1989 |
[The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct].
Topics: Animals; Cardiovascular Agents; Drug Evaluation, Preclinical; Heart; Inosine Diphosphate; Inosine Nucleotides; Isoproterenol; Male; Myocardial Infarction; Myocardium; Pituitary Hormones, Posterior; Quinazolines; Rats; Rats, Inbred Strains | 1989 |
Reversal of changes of lipid peroxide, xanthine oxidase and superoxide dismutase by cardio-protective drugs in isoproterenol induced myocardial necrosis in rats.
Topics: Animals; Cardiovascular Agents; Isoproterenol; Lipid Peroxides; Male; Myocardial Infarction; Oxidoreductases; Pregnenediones; Rats; Superoxide Dismutase; Xanthine Oxidase | 1989 |
Effects of a specific bradycardic agent (AQ-A39) and verapamil on beta-adrenergic responses in isolated guinea pig atria.
Topics: Animals; Cardiovascular Agents; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Isoindoles; Isoproterenol; Male; Myocardial Contraction; Phthalimides; Receptors, Adrenergic, beta; Verapamil | 1987 |
Pharmacologically induced changes in wall thickening dynamics and mid-ventricular volumes in dogs assessed by prospectively gated computed tomography.
Topics: Animals; Blood Pressure; Cardiovascular Agents; Dogs; Electrocardiography; Heart Ventricles; Isoproterenol; Myocardial Contraction; Phenylephrine; Tomography, X-Ray Computed; Verapamil | 1983 |
Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist.
Topics: Animals; Atrial Function; Atropine; Cardiovascular Agents; Clonidine; Dose-Response Relationship, Drug; Electrolytes; Female; Heart Atria; Heart Rate; Hydrogen-Ion Concentration; In Vitro Techniques; Isoproterenol; Male; Membrane Potentials; Myocardial Contraction; Rabbits; Sinoatrial Node | 1981 |
Cardiovascular profile of mixidine fumarate, a compound which attenuates myocardial chronotropic responses.
Topics: Aminophylline; Animals; Blood Pressure; Cardiac Output; Cardiovascular Agents; Cats; Dogs; Drug Interactions; Electric Stimulation; Electrocardiography; Epinephrine; Female; Glucagon; Heart; Heart Rate; Hemodynamics; Isoproterenol; Male; Nictitating Membrane; Physical Exertion; Pyrrolidines; Sympathetic Nervous System | 1980 |
Slowing of shortening velocity of rat cardiac myocytes by adenosine receptor stimulation regardless of beta-adrenergic stimulation.
Topics: Adenosine; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Calcium; Cardiotonic Agents; Cardiovascular Agents; Female; Heart Rate; Isometric Contraction; Isoproterenol; Muscle Proteins; Myocardial Contraction; Myocardium; Phosphorylation; Propranolol; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Sarcomeres | 1995 |
Integrative cardiovascular actions of a novel catecholamine, GP-2-128.
Topics: Adrenergic beta-Antagonists; Animals; Benzamides; Cardiac Output; Cardiovascular Agents; Catecholamines; Dobutamine; Dogs; Female; Half-Life; Heart Rate; Hemodynamics; Injections, Intravenous; Iontophoresis; Isoproterenol; Male; Muscle Contraction; Myocardial Contraction; Stereoisomerism; Vascular Resistance | 1994 |
Interactions of a novel catecholamine, GP-2-128, with adrenoceptors.
Topics: Adipocytes; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Antagonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Aorta, Thoracic; Benzamides; Cardiovascular Agents; Catecholamines; Cricetinae; Dobutamine; Guinea Pigs; Ileum; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Trachea | 1994 |
Hemodynamics and ventricular function in the day-12 rat embryo: basic characteristics and the responses to cardiovascular drugs.
Topics: Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Chick Embryo; Digitalis Glycosides; Female; Fetus; Gestational Age; Hemodynamics; In Vitro Techniques; Isoproterenol; Norepinephrine; Pregnancy; Rats; Rats, Wistar; Species Specificity; Ventricular Function | 1995 |
Measurement of both cyclic [3H]AMP and cyclic [3H]GMP in cultured vascular smooth muscle cells labeled with [3H]hypoxanthine: use in studies of cardiovascular drugs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Triphosphate; Animals; Cardiovascular Agents; Cells, Cultured; Cyclic AMP; Cyclic GMP; Drug Evaluation, Preclinical; Guanosine Triphosphate; Hypoxanthine; Hypoxanthines; Isoproterenol; Isotope Labeling; Muscle, Smooth, Vascular; Nitroprusside; Radioimmunoassay; Rats; Rats, Inbred WKY; Reproducibility of Results; Tritium | 1993 |
Effect of zatebradine on contractility, relaxation and coronary blood flow.
Topics: Animals; Benzazepines; Cardiovascular Agents; Coronary Circulation; Depression, Chemical; Heart Rate; Isoproterenol; Myocardial Contraction; Swine; Verapamil | 1993 |
Activation of adenosine receptors before ischemia enhances tolerance against myocardial stunning in the rabbit heart.
Topics: Adenosine; Adenosine Triphosphate; Adenylyl Cyclases; Analysis of Variance; Animals; Cardiotonic Agents; Cardiovascular Agents; Hemodynamics; Humans; Infusions, Intravenous; Isoproterenol; Lactates; Male; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Rabbits; Receptors, Purinergic P1; Theophylline | 1996 |
The hyperpolarization-activated current (Ih) and its contribution to pacemaker activity in rat CA1 hippocampal stratum oriens-alveus interneurones.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Cardiovascular Agents; Cesium; Electrophysiology; Hippocampus; Isoproterenol; Neurons; Norepinephrine; Patch-Clamp Techniques; Pyrimidines; Rats; Rats, Sprague-Dawley | 1996 |
The effect of age on adenosine A1 receptor function in the rat heart.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenergic beta-Agonists; Age Factors; Animals; Carbachol; Cardiovascular Agents; Cell Membrane; Colforsin; Heart; Isoproterenol; Male; Muscarinic Agonists; Myocardium; Purinergic P1 Receptor Agonists; Rats; Rats, Inbred F344; Receptors, Purinergic P1; Sulfonic Acids; Theophylline | 1997 |
Effects of low temperature on the chronotropic and inotropic responses to zatebradine, E-4031 and verapamil in isolated perfused dog atria.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Benzazepines; Calcium Channel Agonists; Cardiovascular Agents; Cold Temperature; Dogs; Dose-Response Relationship, Drug; Heart Atria; Hypothermia, Induced; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Perfusion; Piperidines; Pyridines; Verapamil | 1998 |
Morphological plasticity and rearrangement of cytoskeletons in pituicytes cultured from adult rat neurohypophysis.
Topics: Adenosine; Animals; Antitoxins; Astrocytes; Azepines; Bucladesine; Cardiovascular Agents; Cell Size; Colchicine; Cytochalasin B; Isoproterenol; Male; Microtubules; Myosin-Light-Chain Kinase; Pituitary Gland, Posterior; Rats; Rats, Wistar; Sulfonamides; Vasodilator Agents | 1999 |
Cardioprotective effect of magnesium chloride in experimental acute myocardial infarction.
Topics: Animals; Calcium Channel Blockers; Cardiovascular Agents; Creatine Kinase; Female; Isoproterenol; Magnesium Chloride; Male; Myocardial Infarction; Rabbits; Verapamil | 1999 |
Cardiovascular studies on different classes of soft drugs.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atropine Derivatives; Biotransformation; Blood Pressure; Bradycardia; Carbachol; Cardiovascular Agents; Drug Design; Ethanolamines; Heart Rate; Isoproterenol; Male; Muscarinic Agonists; Prodrugs; Rats; Rats, Sprague-Dawley; Tropanes | 2000 |
Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Lipid Peroxidation; Male; Membrane Lipids; Myocardial Ischemia; Myocardium; Peroxidase; Propanolamines; Rabbits; Reperfusion Injury; Ventricular Pressure | 2000 |
Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta; Atenolol; Benzaldehydes; Blood Pressure; Cardiovascular Agents; Depression, Chemical; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Heart Rate; Isoproterenol; Labetalol; Mecamylamine; Models, Animal; Muscle, Smooth, Vascular; Myocardial Contraction; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Regression Analysis; Stimulation, Chemical; Vasodilator Agents | 2000 |
Endothelial NO and prostanoid involvement in newborn and juvenile pig pial arteriolar vasomotor responses.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Age Factors; Animals; Animals, Newborn; Arterioles; Bradykinin; Cardiotonic Agents; Cardiovascular Agents; Cerebrovascular Circulation; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Female; Hypercapnia; Iloprost; Indomethacin; Isoproterenol; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Pia Mater; Swine; Vasodilation; Vasodilator Agents | 2001 |
Blockade of hyperpolarization-activated channels modifies the effect of beta-adrenoceptor stimulation.
Topics: Animals; Bradycardia; Cardiovascular Agents; Electrophysiology; Heart; Isoproterenol; Pyrimidines; Rats; Receptors, Adrenergic, beta; Time Factors; Vagotomy; Vagus Nerve | 2002 |
Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective beta1-non-competitive antagonism.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Benzazepines; Cardiovascular Agents; Guinea Pigs; Heart Rate; Hydrolysis; In Vitro Techniques; Indicators and Reagents; Isoproterenol; Magnetic Resonance Spectroscopy; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Myocardial Contraction; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Stereoisomerism; Trachea; Vasodilation | 2003 |
[New research on the mechanism of ergotamine reversal of the hypotensive effects of isopropylarterenol].
Topics: Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Hypotension; Isoproterenol; Norepinephrine; Oxytocics; Research | 1953 |
Effect of ergotamine on the vasodepressor action of isopropylarterenol.
Topics: Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Humans; Isoproterenol; Oxytocics; Sympathomimetics | 1957 |
[Potentiation of the action of isopropylnoradrenaline by pyrogallol].
Topics: Cardiovascular Agents; Isoproterenol; Muscle Relaxants, Central; Pyrogallol | 1962 |
[OUR EXPERIENCE WITH A SPASMOLYTIC IN BRONCHIAL PATHOLOGY].
Topics: Acetylcholine; Asthma; Bronchial Diseases; Cardiovascular Agents; Isoproterenol; Muscle Relaxants, Central; Parasympatholytics | 1963 |
ADRENERGIC CONSTRICTION IN ISOLATED GUINEA-PIG LING REVEALED BY NETHALIDE.
Topics: Adrenergic Agents; Cardiovascular Agents; Constriction; Dihydroergotoxine; Ergot Alkaloids; Guinea Pigs; Isoproterenol; Lung; Norepinephrine; Pharmacology; Phentolamine; Research; Sympatholytics; Tolazoline | 1964 |
EFFECTS OF SEVERAL CARDIOVASCULAR DRUGS ON VARIOUS PHASES OF CIRCULATORY DYNAMICS.
Topics: Blood Flow Velocity; Blood Pressure; Blood Pressure Determination; Cardiovascular Agents; Epinephrine; Heart; Homeostasis; Humans; Isoproterenol; Methoxamine; Nitroglycerin; Norepinephrine; Pharmacology; Rats; Research; Vagotomy | 1964 |
BRONCHODILATING EFFECT OF BRONTINE AND ISOPRENALINE. ADDITIVE ACTION OF ISOPRENALINE INHALATION RESPECTIVE EPINEPHRINE INJECTION.
Topics: Aerosols; Bronchodilator Agents; Cardiovascular Agents; Drug Synergism; Epinephrine; Humans; Isoproterenol; Muscle Relaxants, Central; Pharmacology; Respiratory Insufficiency; Spirometry | 1964 |
Biochemical changes on the cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amlodipine; Animals; Cardiovascular Agents; Drug Synergism; Isoproterenol; Lipid Metabolism; Male; Mitochondria, Heart; Myocardial Infarction; Nicorandil; Oxidation-Reduction; Rats; Rats, Wistar; Succinic Acid | 2003 |
[The mechanism of the inversion of the hypotensive effects of isoprenaline by ergotamine].
Topics: Blood Pressure; Blood Pressure Determination; Cardiovascular Agents; Ergot Alkaloids; Ergotamine; Humans; Hypotension; Isoproterenol; Sympatholytics | 1952 |
Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiovascular Agents; Female; Heart Failure; Humans; Isoproterenol; Lipopolysaccharides; Male; Norepinephrine; Receptors, Adrenergic, beta; Tumor Necrosis Factor-alpha | 2005 |
Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart.
Topics: Adrenergic beta-Agonists; Amino Acid Sequence; Animals; Cardiovascular Agents; Chromogranin A; Chromogranins; Heart; Heart Rate; Homeostasis; In Vitro Techniques; Isoproterenol; Male; Molecular Sequence Data; Myocardial Contraction; Peptide Fragments; Rats; Rats, Wistar; Recombinant Proteins; Sequence Alignment | 2006 |
Effects of cardioactive medications on retrograde conduction: continuing relevance for current devices.
Topics: Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; Cardiovascular Agents; Combined Modality Therapy; Defibrillators, Implantable; Drug Resistance; Drug Therapy, Combination; Electrophysiologic Techniques, Cardiac; Female; Heart Block; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Pacemaker, Artificial; Research Design; Tachycardia; Treatment Outcome | 2006 |
Comparative analysis of direction, value, and duration atrial pressure of shifts caused by depressor agents.
Topics: Acetylcholine; Animals; Atrial Function; Blood Circulation; Blood Pressure; Cardiac Output; Cardiovascular Agents; Cats; Histamine; Isoproterenol; Time Factors | 2006 |
Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats.
Topics: Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Heart; Isoproterenol; Lysosomes; Male; Myocardial Infarction; Rats; Rats, Wistar; Subcellular Fractions; Time Factors | 2008 |
Synthesis of ranolazine metabolites and their anti-myocardial ischemia activities.
Topics: Acetanilides; Animals; Cardiovascular Agents; Drug Evaluation, Preclinical; Electrocardiography; Female; Glucose; Isoproterenol; Male; Mice; Mice, Inbred Strains; Myocardial Ischemia; Oxidation-Reduction; Piperazines; Ranolazine | 2009 |
PAI-1-derived peptide EEIIMD prevents impairment of cerebrovasodilation by augmenting p38 MAPK upregulation after cerebral hypoxia/ischemia.
Topics: Animals; Animals, Newborn; Anthracenes; Blood Pressure; Carbon Dioxide; Cardiovascular Agents; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Female; Hypercapnia; Hypotension; Hypoxia-Ischemia, Brain; Imidazoles; Injections, Intravenous; Isoproterenol; JNK Mitogen-Activated Protein Kinases; Male; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pia Mater; Protein Kinase Inhibitors; Pyridines; Swine; Time Factors; Up-Regulation; Vasodilation; Vasodilator Agents | 2010 |
Effects of polydatin on attenuating ventricular remodeling in isoproterenol-induced mouse and pressure-overload rat models.
Topics: Aldosterone; Angiotensin II; Animals; Aorta, Abdominal; Blood Pressure; Cardiovascular Agents; Collagen; Cyclic AMP; Drugs, Chinese Herbal; Endothelin-1; Fallopia japonica; Glucosides; Heart; Hypertrophy, Left Ventricular; Isoproterenol; Male; Mice; Myocytes, Cardiac; Organ Size; Phytotherapy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Stilbenes; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2010 |
Ramipril-like activity of Spondias mombin linn against no-flow ischemia and isoproterenol-induced cardiotoxicity in rat heart.
Topics: Anacardiaceae; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Catalase; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Isoproterenol; L-Lactate Dehydrogenase; Male; Malondialdehyde; Myocardial Infarction; Myocardial Ischemia; Myocardium; Nitrites; No-Reflow Phenomenon; Phosphates; Plant Extracts; Plant Leaves; Ramipril; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Time Factors | 2010 |
Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Animals; Aortic Valve; Blood Pressure; Body Weight; Cardiomyopathies; Cardiovascular Agents; Collagen; Disease Models, Animal; Drug Administration Schedule; Dystrophin; Female; Fibrosis; Heart Rate; Injections, Intraperitoneal; Isoproterenol; Mice; Mice, Inbred mdx; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Myocardial Contraction; Myocardium; Poloxamer; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2011 |
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Heart Rate; Humans; Imidazoles; Isoproterenol; Male; Phenoxyacetates; Phenoxypropanolamines; Propanolamines; Rats; Rats, Sprague-Dawley; Vascular Resistance; Xamoterol | 2011 |
Protective effects of Carthamus tinctorius injection on isoprenaline-induced myocardial injury in rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cardiovascular Agents; Carthamus tinctorius; Disease Models, Animal; Drugs, Chinese Herbal; Electrocardiography; Female; Inflammation Mediators; Injections, Intraperitoneal; Interleukin-6; Isoproterenol; Male; Myocardial Ischemia; Myocardium; Plant Preparations; Plants, Medicinal; Protective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Cardioprotective effect of HPLC standardized ethanolic extract of Terminalia pallida fruits against isoproterenol-induced myocardial infarction in albino rats.
Topics: Adenosine Triphosphatases; Animals; Antioxidants; Biomarkers; Cardiovascular Agents; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Fruit; Isoproterenol; Lipid Peroxidation; Lipids; Male; Myocardial Infarction; Myocardium; Phytotherapy; Plant Extracts; Plants, Medicinal; Protective Agents; Rats; Rats, Wistar; Solvents; Spectrometry, Mass, Electrospray Ionization; Terminalia; Time Factors | 2012 |
Desmodium gangeticum (Linn.) DC. exhibits antihypertrophic effect in isoproterenol-induced cardiomyoblasts via amelioration of oxidative stress and mitochondrial alterations.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Cardiomegaly; Cardiovascular Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Fabaceae; Isoproterenol; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myoblasts, Cardiac; Oxidative Stress; Phenols; Plant Extracts; Rats; Reactive Oxygen Species; Time Factors | 2013 |
Cardiovascular effects of vanillylmandelic acid in rats.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Blood Pressure; Cardiovascular Agents; Epinephrine; Female; Heart Rate; Isoproterenol; Rats; Rats, Wistar; Vagotomy; Vagus Nerve Stimulation; Vanilmandelic Acid | 2013 |
Screening and identifying the myocardial-injury protective ingredients from Sheng-Mai-San.
Topics: Animals; Biomarkers; Cardiovascular Agents; Chromatography, Liquid; Creatine Kinase; Cytoprotection; Disease Models, Animal; Drug Combinations; Drugs, Chinese Herbal; Isoproterenol; L-Lactate Dehydrogenase; Malondialdehyde; Mice; Mice, Inbred ICR; Myocardial Infarction; Myocardium; Peroxidase; Phytotherapy; Plants, Medicinal; Superoxide Dismutase; Tandem Mass Spectrometry | 2013 |
An optical multi-sensing system for detection of cardiovascular toxicity.
Topics: Animals; Cardiovascular Agents; Cells, Cultured; Chick Embryo; Isoproterenol; Microscopy; Myocytes, Cardiac; Optical Imaging | 2014 |
Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells.
Topics: Action Potentials; Aniline Compounds; Animals; Benzazepines; Caffeine; Calcium; Cardiovascular Agents; Cell Differentiation; Cell Line; Cellular Reprogramming; Connexin 43; Dependovirus; Genetic Vectors; Humans; Induced Pluripotent Stem Cells; Isoproterenol; Ivabradine; Microtubules; Myocytes, Cardiac; Patch-Clamp Techniques; Phenyl Ethers; Sarcoplasmic Reticulum; Sodium-Calcium Exchanger; Tetracaine; Transfection | 2015 |
Acute isoproterenol induces anxiety-like behavior in rats and increases plasma content of extracellular vesicles.
Topics: Animals; Anxiety; Blood Chemical Analysis; Blotting, Western; Cardiovascular Agents; Corticosterone; Electrocardiography; Extracellular Vesicles; Heart Rate; HSP70 Heat-Shock Proteins; Isoproterenol; Male; MicroRNAs; Motor Activity; Psychotropic Drugs; Rats, Sprague-Dawley | 2015 |
PP2 prevents isoproterenol stimulation of cardiac pacemaker activity.
Topics: Animals; Antineoplastic Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Cardiovascular Agents; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channel Gating; Isoproterenol; Phosphorylation; Rats; Sinoatrial Node; src-Family Kinases | 2015 |
CPUY11018, an azimilide derivative, ameliorates isoproterenol-induced cardiac insufficiency through relieving dysfunctional mitochondria and endoplasmic reticulum.
Topics: Acetophenones; Animals; Biomarkers; Cardiovascular Agents; Carrier Proteins; Cell Culture Techniques; Dose-Response Relationship, Drug; Down-Regulation; Endoplasmic Reticulum; Fibroblasts; Heart Failure; Hemodynamics; Hydantoins; Hydrazones; Inflammation Mediators; Isoproterenol; Male; Mitochondria; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Up-Regulation | 2015 |
Right-to-left frequency gradient during atrial fibrillation initiated by right atrial ectopies and its augmentation by adenosine triphosphate: Implications of right atrial fibrillation.
Topics: Adenosine Triphosphate; Adult; Aged; Atrial Fibrillation; Atrial Premature Complexes; Cardiovascular Agents; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Humans; Isoproterenol; Middle Aged; Preoperative Care | 2016 |
Nicorandil enhances the efficacy of mesenchymal stem cell therapy in isoproterenol-induced heart failure in rats.
Topics: Animals; Cardiovascular Agents; Drug Therapy, Combination; Heart Failure; Isoproterenol; Male; Mesenchymal Stem Cell Transplantation; Nicorandil; Rats; Rats, Wistar | 2015 |
Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
Topics: Action Potentials; Animals; Cardiac Electrophysiology; Cardiovascular Agents; Cilostazol; Death, Sudden, Cardiac; Disease Models, Animal; Dogs; Electrocardiography; Ion Channels; Isoproterenol; Milrinone; Tachycardia, Ventricular; Tetrazoles; Ventricular Fibrillation | 2016 |
Gap junction modifiers regulate electrical activities of the sinoatrial node and pulmonary vein: Therapeutic implications in atrial arrhythmogenesis.
Topics: Action Potentials; Aminoquinolines; Animals; Atrial Fibrillation; Cardiovascular Agents; Gap Junctions; Heart Atria; Heptanol; Isoproterenol; Myocytes, Cardiac; Pulmonary Veins; Rabbits; Sinoatrial Node | 2016 |
Oligomeric proanthocyanidins protect myocardium by mitigating left ventricular remodeling in isoproterenol-induced postmyocardial infarction.
Topics: Animals; Antioxidants; Bone Morphogenetic Protein 4; Cardiovascular Agents; Collagen; Disease Models, Animal; Fibrosis; Isoproterenol; Lipid Peroxidation; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Oxidative Stress; Proanthocyanidins; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Effect of ethanolic extract of Cyperus rotundus L. against isoprenaline induced cardiotoxicity.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Cardiotoxicity; Cardiovascular Agents; Cyperus; Cytoprotection; Disease Models, Animal; Ethanol; Isoproterenol; Male; Metoprolol; Myocardial Infarction; Myocardium; Necrosis; Phytotherapy; Plant Extracts; Plants, Medicinal; Ramipril; Rats, Wistar; Rhizome; Solvents | 2016 |
Anti-fibrotic Actions of Roselle Extract in Rat Model of Myocardial Infarction.
Topics: Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Collagen Type I; Collagen Type III; Disease Models, Animal; Fibrosis; Heart Ventricles; Hibiscus; Hypertrophy, Left Ventricular; Inflammation Mediators; Interleukin-10; Interleukin-6; Isoproterenol; Male; Myocardial Infarction; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats, Wistar; Troponin T; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Protective Action of Diazoxide on Isoproterenol-Induced Hypertrophy Is Mediated by Reduction in MicroRNA-132 Expression.
Topics: Animals; Animals, Newborn; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Diazoxide; Disease Models, Animal; Isoproterenol; Male; MicroRNAs; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Rats, Wistar; Reactive Oxygen Species; Signal Transduction | 2018 |
Fabrication of ultra-small nanocrystals by formation of hydrogen bonds: In vitro and in vivo evaluation.
Topics: Animals; Biological Availability; Caco-2 Cells; Cardiovascular Agents; Diffusion; Disease Models, Animal; Humans; Hydrogen Bonding; Isoflavones; Isoproterenol; Male; Myocardial Ischemia; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Solubility | 2020 |
Micro-patterned SU-8 cantilever integrated with metal electrode for enhanced electromechanical stimulation of cardiac cells.
Topics: Animals; Biosensing Techniques; Cardiovascular Agents; Epoxy Compounds; Isoproterenol; Lidocaine; Mechanical Phenomena; Myocytes, Cardiac; Particle Size; Polymers; Surface Properties; Verapamil | 2020 |
Calycosin reduces infarct size, oxidative stress and preserve heart function in isoproterenol-induced myocardial infarction model.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cardiovascular Agents; Disease Models, Animal; Inflammation Mediators; Isoflavones; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Ventricular Function | 2020 |
Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Fibrosis; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Peptide Fragments; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Ventricular Remodeling | 2021 |
Modified citrus pectin prevents isoproterenol-induced cardiac hypertrophy associated with p38 signalling and TLR4/JAK/STAT3 pathway.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiovascular Agents; Disease Models, Animal; Galectin 3; Isoproterenol; Janus Kinase 2; Male; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; p38 Mitogen-Activated Protein Kinases; Pectins; Phosphorylation; Rats, Wistar; Signal Transduction; STAT3 Transcription Factor; Toll-Like Receptor 4; Ventricular Function, Left; Ventricular Remodeling | 2021 |